Symbionics is a brain-computer interface company that focuses on the development of interface devices to integrate humans and machines.
Symbionics has raised $4.1M in total funding. The most recent round was Angel. The last funding was announced in October 2023.
Symbionics's investors include Kunlun Capital.
Symbionics is headquartered in Cambridge, United States.
Symbionics is a brain-computer interface company that focuses on the development of interface devices to integrate humans and machines.
Symbionics is at the Angel stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Symbionics — Funding & Investors." VCBacked, October 24, 2023, https://www.vcbacked.co/company/symbionics. Accessed August 14, 2026.
VCBacked. (2023). Symbionics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/symbionics
{{cite web |title=Symbionics — Funding & Investors |url=https://www.vcbacked.co/company/symbionics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated